• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LINC00240 通过 HGF/c-MET 信号通路吸附 miR-4465 促进肝癌细胞的增殖、迁移和侵袭。

LINC00240 sponges miR-4465 to promote proliferation, migration, and invasion of hepatocellular carcinoma cells via HGF/c-MET signaling pathway.

机构信息

Department of Oncology, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.

出版信息

Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10452-10461. doi: 10.26355/eurrev_202010_23397.

DOI:10.26355/eurrev_202010_23397
PMID:33155201
Abstract

OBJECTIVE

LINC00240, as a novel long non-coding RNAs (lncRNAs), has never been studied in hepatocellular carcinoma (HCC). This research reported the expression and function of LINC00240 in HCC.

PATIENTS AND METHODS

LINC00240 expression in 180 HCC patients was downloaded from the Cancer Genome Atlas (TCGA) database. HCC patients' survival was analyzed via Kaplan‑Meier analysis. The expression of LINC00240, miR-4465 and HGF in Hep3B and Huh7 cells were regulated by transfection. Cell viability was determined by MTT assay. Transwell experiment was used for the detection of cells migration and invasion abilities. The interaction between LINC00240, miR-4465 and HGF was reflected by Luciferase reporter assay. LINC00240, miR-4465, HGF and p-c-MET expression in HCC cells were researched by real-time quantitative polymerase chain reaction (RT-qPCR) and Western blot.

RESULTS

TCGA data showed that high LINC00240 expression was markedly associated with lower survival of HCC patients (p = 0.036). LINC00240 expression was aberrantly upregulated in HCC cells. Silencing of LINC00240 significantly reduced HCC cells viability, migration and invasion. miR-4465 was a target gene of LINC00240. Silencing of LINC00240 reduced HCC cells viability, migration and invasion via directly promoting miR-4465 expression. HGF was target gene of miR-4465. miR-4465 up-regulation obviously suppressed HGF and p-c-MET expression. According to rescue experiment, LINC00240 silencing inhibited HCC cells viability, migration and invasion by suppressing HGF/c-MET signaling pathway via targeting miR-4465.

CONCLUSIONS

LINC00240 sponges miR-4465 to promote HCC cells proliferation, migration and invasion via HGF/c-MET signaling pathway.

摘要

目的

LINC00240 作为一种新型长链非编码 RNA(lncRNA),尚未在肝细胞癌(HCC)中进行研究。本研究报道了 LINC00240 在 HCC 中的表达和功能。

患者和方法

从癌症基因组图谱(TCGA)数据库中下载了 180 例 HCC 患者的 LINC00240 表达数据。通过 Kaplan-Meier 分析对 HCC 患者的生存情况进行分析。通过转染调节 Hep3B 和 Huh7 细胞中 LINC00240、miR-4465 和 HGF 的表达。通过 MTT 测定法测定细胞活力。通过 Transwell 实验检测细胞迁移和侵袭能力。通过荧光素酶报告实验反映 LINC00240、miR-4465 和 HGF 之间的相互作用。通过实时定量聚合酶链反应(RT-qPCR)和 Western blot 研究 HCC 细胞中的 LINC00240、miR-4465、HGF 和 p-c-MET 的表达。

结果

TCGA 数据表明,高 LINC00240 表达与 HCC 患者生存率降低显著相关(p=0.036)。LINC00240 在 HCC 细胞中表达异常上调。沉默 LINC00240 可显著降低 HCC 细胞活力、迁移和侵袭。miR-4465 是 LINC00240 的靶基因。沉默 LINC00240 通过直接促进 miR-4465 表达来降低 HCC 细胞活力、迁移和侵袭。HGF 是 miR-4465 的靶基因。miR-4465 的上调明显抑制了 HGF 和 p-c-MET 的表达。根据挽救实验,沉默 LINC00240 通过靶向 miR-4465 抑制 HCC 细胞活力、迁移和侵袭,抑制 HGF/c-MET 信号通路。

结论

LINC00240 通过海绵 miR-4465 促进 HCC 细胞增殖、迁移和侵袭,通过 HGF/c-MET 信号通路。

相似文献

1
LINC00240 sponges miR-4465 to promote proliferation, migration, and invasion of hepatocellular carcinoma cells via HGF/c-MET signaling pathway.LINC00240 通过 HGF/c-MET 信号通路吸附 miR-4465 促进肝癌细胞的增殖、迁移和侵袭。
Eur Rev Med Pharmacol Sci. 2020 Oct;24(20):10452-10461. doi: 10.26355/eurrev_202010_23397.
2
miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway.miR-198 通过靶向 HGF/c-MET 通路抑制肝癌细胞的迁移和侵袭。
FEBS Lett. 2011 Jul 21;585(14):2229-34. doi: 10.1016/j.febslet.2011.05.042. Epub 2011 Jun 7.
3
MicroRNA-101-3p suppresses proliferation and migration in hepatocellular carcinoma by targeting the HGF/c-Met pathway.miR-101-3p 通过靶向 HGF/c-Met 通路抑制肝癌细胞的增殖和迁移。
Invest New Drugs. 2020 Feb;38(1):60-69. doi: 10.1007/s10637-019-00766-8. Epub 2019 Mar 30.
4
MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway.miRNA-449a 通过 G1 期阻滞和 HGF/MET c-Met 通路抑制肝癌细胞生长。
Hepatobiliary Pancreat Dis Int. 2018 Aug;17(4):336-344. doi: 10.1016/j.hbpd.2018.07.006. Epub 2018 Jul 26.
5
CYP1A2 suppresses hepatocellular carcinoma through antagonizing HGF/MET signaling.CYP1A2 通过拮抗 HGF/MET 信号抑制肝细胞癌。
Theranostics. 2021 Jan 1;11(5):2123-2136. doi: 10.7150/thno.49368. eCollection 2021.
6
The Long Non-Coding RNA CASC2 Suppresses Cell Viability, Migration, and Invasion in Hepatocellular Carcinoma Cells by Directly Downregulating miR-183.长链非编码 RNA CASC2 通过直接下调 miR-183 抑制肝癌细胞的活力、迁移和侵袭。
Yonsei Med J. 2019 Oct;60(10):905-913. doi: 10.3349/ymj.2019.60.10.905.
7
MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway.MicroRNA-26a 通过靶向肝细胞生长因子-cMet 通路抑制人肝癌血管生成。
Hepatology. 2014 May;59(5):1874-85. doi: 10.1002/hep.26941. Epub 2014 Apr 1.
8
Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway.中药配方七方化癥汤通过 HGF/c-Met 信号通路抑制肝癌转移。
Biomed Pharmacother. 2020 Dec;132:110867. doi: 10.1016/j.biopha.2020.110867. Epub 2020 Oct 16.
9
lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.长链非编码 RNA MIAT 通过海绵吸附 miR-214 促进 HCC 细胞的增殖和侵袭。
Am J Physiol Gastrointest Liver Physiol. 2018 May 1;314(5):G559-G565. doi: 10.1152/ajpgi.00242.2017. Epub 2017 Nov 2.
10
Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.长链非编码 RNA CRNDE 通过 miR-217/MAPK1 轴促进肝癌细胞的增殖、迁移和侵袭。
J Cell Mol Med. 2018 Dec;22(12):5862-5876. doi: 10.1111/jcmm.13856. Epub 2018 Sep 24.

引用本文的文献

1
LncRNA THUMPD3-AS1/microRNA-4465/KPNA2 axis impacts human hepatocellular carcinoma cell phenotypes.长链非编码RNA THUMPD3-AS1/微小RNA-4465/KPNA2轴影响人肝癌细胞表型。
Regen Ther. 2025 Jan 23;28:413-420. doi: 10.1016/j.reth.2025.01.010. eCollection 2025 Mar.
2
Molecular Mechanisms in Tumorigenesis of Hepatocellular Carcinoma and in Target Treatments-An Overview.肝癌发生的分子机制与靶向治疗概述。
Biomolecules. 2024 Jun 4;14(6):656. doi: 10.3390/biom14060656.
3
Signaling pathways in liver cancer: pathogenesis and targeted therapy.
肝癌信号通路:发病机制与靶向治疗。
Mol Biomed. 2024 May 31;5(1):20. doi: 10.1186/s43556-024-00184-0.
4
Role of LINC00240 on T-helper 9 differentiation in allergic rhinitis through influencing DNMT1-dependent methylation of PU.1.LINC00240 通过影响 DNMT1 依赖性 PU.1 甲基化在变应性鼻炎中调节辅助性 T 细胞 9 分化的作用。
Immunol Res. 2024 Apr;72(2):197-211. doi: 10.1007/s12026-023-09435-8. Epub 2023 Nov 15.
5
MicroRNAs as Potential Regulators of GSK-3β in Renal Cell Carcinoma.微小RNA作为肾细胞癌中糖原合成酶激酶-3β的潜在调节因子
Curr Issues Mol Biol. 2023 Sep 11;45(9):7432-7448. doi: 10.3390/cimb45090470.
6
Knockdown of Long Noncoding RNA LINC00240 Inhibits Esophageal Cancer Progression by Regulating miR-26a-5p.长链非编码 RNA LINC00240 的敲低通过调节 miR-26a-5p 抑制食管癌进展。
Contrast Media Mol Imaging. 2022 Oct 5;2022:1071627. doi: 10.1155/2022/1071627. eCollection 2022.
7
LARRPM restricts lung adenocarcinoma progression and M2 macrophage polarization through epigenetically regulating LINC00240 and CSF1.LRRPM 通过表观遗传调控 LINC00240 和 CSF1 限制肺腺癌进展和 M2 巨噬细胞极化。
Cell Mol Biol Lett. 2022 Oct 11;27(1):91. doi: 10.1186/s11658-022-00376-y.
8
Identify Functional lncRNAs in Nonalcoholic Fatty Liver Disease by Constructing a ceRNA Network.通过构建ceRNA网络鉴定非酒精性脂肪性肝病中的功能性长链非编码RNA
ACS Omega. 2022 Jun 22;7(26):22522-22530. doi: 10.1021/acsomega.2c01801. eCollection 2022 Jul 5.
9
CircATIC Contributes to Multiple Myeloma Progression via miR-324-5p-Dependent Regulation of HGF.环状 RNA 转录激活因子通过 miR-324-5p 依赖调控 HGF 促进多发性骨髓瘤进展。
Biochem Genet. 2022 Dec;60(6):2515-2532. doi: 10.1007/s10528-022-10228-1. Epub 2022 May 17.
10
LINC00240 knockdown inhibits nasopharyngeal carcinoma progress by targeting miR-26a-5p.LINC00240 敲低通过靶向 miR-26a-5p 抑制鼻咽癌进展。
J Clin Lab Anal. 2022 May;36(5):e24424. doi: 10.1002/jcla.24424. Epub 2022 Apr 14.